Ascribe Bioscience

United States
Boscawen, New Hampshire, United States, 14853

Company profile

Ascribe Bioscience company profile

Ascribe Bioscience develops products that enable farmers to combat crop pathogens without negative impacts on the environment. The company is currently developing a seed treatment product that acts by boosting crops’ natural defenses. Ascribe Bioscience was founded in 2017 and is headquartered in Ithaca, New York.

Business identity

Phone number
607-703-9083
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2017-01-01, Year

Headquarters

Postal code
14853
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
8
Total equity funding
$17.7M
Last funding
Series A / $12M / 2025-10-14
Last equity funding
Series A / $12M
Investors
12
Lead investors
7
Founders
2
Articles
25

Founders and investors

Founders

Jay FarmerMurli Manohar

Lead investors

Acre Venture PartnersCorteva CatalystCultivation CapitalGrow-NYNational Science FoundationSource Agriventures Inc.The Yield Lab

Investors

Acre Venture PartnersCreative Destruction Lab (CDL)Cultivation CapitalNational Science FoundationThe Yield Lab